Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?
depression
mental health nursing
psilocybin
psychedelics
psychotherapy
treatment-resistant depression
Journal
International journal of mental health nursing
ISSN: 1447-0349
Titre abrégé: Int J Ment Health Nurs
Pays: Australia
ID NLM: 101140527
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
revised:
06
08
2023
received:
19
05
2023
accepted:
08
08
2023
medline:
27
11
2023
pubmed:
17
8
2023
entrez:
17
8
2023
Statut:
ppublish
Résumé
This perspective paper explores the choice of psychotherapy for psilocybin-assisted psychotherapy for treatment-resistant depression. There is evidence to support the use of some psychotherapies in treating 'treatment-resistant' depression, and emerging evidence for the efficacy of psilocybin. The next step which is the focus of this paper is to identify psychotherapies that are both effective and congruent with the psilocybin experience. The evidence for the efficacy of the psychotherapies is drawn from a Cochrane review and the analysis of their congruence with the psilocybin experience is drawn from a qualitative meta-synthesis of the experience of psilocybin. The paper will examine whether three one-to-one psychotherapies identified as effective in the treatment of treatment-resistant depression are compatible with the psilocybin experience. Each psychotherapy will be examined in relation to its congruence with the qualitative evidence that suggests the choice of psychotherapy needs to give priority to the subjective experience, facilitate emotional processing, support connectedness with others, acceptance of the self as emotional and support change based on the person's insights into their relationships with others and the world in which they live. We conclude that interpersonal psychotherapy and intensive short-term dynamic psychotherapy align with that experience, although others are currently being trialled.
Substances chimiques
Psilocybin
2RV7212BP0
Hallucinogens
0
Types de publication
Journal Article
Langues
eng
Pagination
1766-1772Informations de copyright
© 2023 The Authors. International Journal of Mental Health Nursing published by John Wiley & Sons Australia, Ltd.
Références
Abbass, A., Town, J. & Driessen, E. (2012) Intensive short-term dynamic psychotherapy: a systematic review and meta-analysis of outcome research. Harvard Review of Psychiatry, 20(2), 97-108. Available from: https://doi.org/10.3109/10673229.2012.677347
Abbass, A., Town, J. & Driessen, E. (2013) Intensive short-term dynamic psychotherapy: a review of the treatment method and empirical basis. Research in Psychotherapy: Psychopathology, Process and Outcome, 16, 6-15.
Al-Naggar, R., Alshaikhli, H. & Erlam, G. (2021) Effectiveness of psilocybin on depression: a qualitative study. Electronic Journal of General Medicine, 18, 296.
Beck, A., Rush, A.J., Shaw, B. & Emery, G. (1987) Cognitive therapy of depression. New York: Guilford Press.
Belser, A., Agin-Liebes, G., Swift, T., Terrana, S., Devenot, N., Friedman, H. et al. (2017) Patient experiences of psilocybin-assisted psychotherapy: an interpretative phenomenological analysis. Journal of Humanistic Psychology, 57, 354-388.
Berg, H. & Slaattelid, R. (2017) Facts and values in psychotherapy-a critique of the empirical reduction of psychotherapy within evidence-based practice. Journal of Evaluation in Clinical Practice, 23(5), 1075-1080. Available from: https://doi.org/10.1111/jep.12739
Bogenschutz, M.P. (2017) It's time to take psilocybin seriously as a possible treatment for substance use disorders. The American Journal of Drug and Alcohol Abuse, 43(1), 4-6. Available from: https://doi.org/10.1080/00952990.2016.1200060
Bowlby, J. (1969) Attachment and loss, vol 1: attachment. London: Hogarth Press and the Institute of Psycho-analysis.
Brown, S., Rittenbach, K., Cheung, S., McKean, G., MacMaster, F. & Clement, F. (2019) Current and common definitions of treatment-resistant depression: findings from a systematic review and qualitative interviews. The Canadian Journal of Psychiatry, 64, 380-387.
Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R. et al. (2021) Trial of psilocybin versus escitalopram for depression. The New England Journal of Medicine, 384(15), 1402-1411. Available from: https://doi.org/10.1056/NEJMoa2032994
Carhart-Harris, R. & Nutt, D. (2010) User perceptions of the benefits and harms of hallucinogenic drug use: a web-based questionnaire study. Journal of Substance Use, 15, 283-300.
Carhart-Harris, R.L., Bolstridge, M., Rucker, J., Day, C.M., Erritzoe, D., Kaelen, M. et al. (2016) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry, 3(7), 619-627. Available from: https://doi.org/10.1016/S2215-0366(16)30065-7
Carhart-Harris, R.L., Erritzoe, D., Haijen, E., Kaelen, M. & Watts, R. (2018) Psychedelics and connectedness. Psychopharmacology, 235(2), 547-550. Available from: https://doi.org/10.1007/s00213-017-4701-y
Corneille, J.S. & Luke, D. (2021) Spontaneous spiritual awakenings: phenomenology, altered states, individual differences, and well-being. Frontiers in Psychology, 12, 720579. Available from: https://doi.org/10.3389/fpsyg.2021.720579
Crowe, M., Inder, M. & McCall, C. (2022) The experience of antidepressant use and discontinuation: a qualitative synthesis of the evidence. Journal of Psychiatric and Mental Health Nursing, 30, 21-34. Available from: https://doi.org/10.1111/jpm.12850
Crowe, M., Manuel, J., Carlyle, D. & Lacey, C. (2023a) Experiences of psilocybin treatment for clinical conditions: a qualitative meta-synthesis. International Journal of Mental Health Nursing, 32, 1025-1037. Available from: https://doi.org/10.1111/inm.13127
Crowe, M., Manuel, J., Carlyle, D. & Lacey, C. (2023b) Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis. International Journal of Mental Health Nursing, 32, 1025-1037.
Crowe, M., Manuel, J., Carlyle, D., Thwaites, B. & Lacey, C. (2023) The experience of 'treatment-resistant' depression: a qualitative meta-synthesis. International Journal of Mental Health Nursing, 32, 662-672. Available from: https://doi.org/10.1111/inm.13107
Cuijpers, P., van Straten, A., Andersson, G. & van Oppen, P. (2008) Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. Journal of Consulting and Clinical Psychology, 76(6), 909-922. Available from: https://doi.org/10.1037/a0013075
Deacon, B.J. (2013) The biomedical model of mental disorder: a critical analysis of its validity, utility, and effects on psychotherapy research. Clinical Psychology Review, 33(7), 846-861. Available from: https://doi.org/10.1016/j.cpr.2012.09.007
Forstmann, M., Yudkin, D.A., Prosser, A.M.B., Heller, S.M. & Crockett, M.J. (2020) Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings. Proceedings of the National Academy of Sciences of the United States of America, 117(5), 2338-2346. Available from: https://doi.org/10.1073/pnas.1918477117
Gerrans, P. & Letheby, C. (2017) Model hallucinations. London: Aeon. Available from: https://aeon.co/essays/psychedelics-work-by-violating-our-models-of-self-and-the-world
Goodwin, G.M., Malievskaia, E., Fonzo, G.A. & Nemeroff, C.B. (2023) Must psilocybin always "assist psychotherapy"? The American Journal of Psychiatry, appiajp20221043. Available from: https://doi.org/10.1176/appi.ajp.20221043
Griffiths, R., Richards, W., Johnson, M., McCann, U. & Jesse, R. (2008) Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology, 22(6), 621-632. Available from: https://doi.org/10.1177/0269881108094300
Guss, J., Krause, R. & Sloshower, J. (2020) Yale manual for psilocybin-assisted therapy of depression. New Haven, CT: Yale University.
Hayes, S. (2004) Acceptance and commitment therapy, relational frame theory, and the third wave of behavioural and cognitive therapies. Behaviour Therapy, 35, 639-665.
Horton, D.M., Morrison, B. & Schmidt, J. (2021) Systematized review of psychotherapeutic components of psilocybin-assisted psychotherapy. American Journal of Psychotherapy, 74(4), 140-149. Available from: https://doi.org/10.1176/appi.psychotherapy.20200055
Hurley, J., Lakeman, R., Cashin, A. & Ryan, T. (2020) Mental health nurse psychotherapists are well situated to improve service shortfalls in Australia: findings from a qualitative study. Australasian Psychiatry, 28(4), 423-425. Available from: https://doi.org/10.1177/1039856220924326
Ijaz, S., Davies, P., Williams, C., Kessler, D., Lewis, G. & Wiles, N. (2018) Psychological therapies for treatment-resistant depression in adults. Cochrane Database of Systematic Reviews, 5, CD010558. Available from: https://doi.org/10.1002/14651858.CD010558.pub2
Kaluzna, A., Schlosser, M., Craste, E., Stroud, J. & Cooke, J. (2022) Being no one, being one: the role of ego-dissolution and connectedness in the therapeutic effects of psychedelic experience. Journal of Psychedelic Studies, 2, 111-136.
Kargbo, R.B. (2020) Psilocybin therapeutic research: the present and future paradigm. ACS Medicinal Chemistry Letters, 11(4), 399-402. Available from: https://doi.org/10.1021/acsmedchemlett.0c00048
Leichsenring, F., Abbass, A., Hilsenroth, M.J., Luyten, P., Munder, T., Rabung, S. et al. (2018) "Gold standards," plurality and monocultures: the need for diversity in psychotherapy. Frontiers in Psychiatry, 9, 159. Available from: https://doi.org/10.3389/fpsyt.2018.00159
Letheby, C. (2021) The mechanisms of psychedelic therapy. In: Letheby, C. (Ed.) Philosophy of psychedelics. Oxford: Oxford University Press, pp. 62-108.
Lipsitz, J.D. & Markowitz, J.C. (2013) Mechanisms of change in interpersonal therapy (IPT). Clinical Psychology Review, 33(8), 1134-1147. Available from: https://doi.org/10.1016/j.cpr.2013.09.002
Markowitz, J.C. (2014) What is supportive psychotherapy? Focus, 12, 249-371.
Marzillier, J. (2014) The flawed nature of evidence-based psychotherapy. Psychotherapy Section Review, 51, 25-33.
Mason, N.L., Kuypers, K.P.C., Muller, F., Reckweg, J., Tse, D.H.Y., Toennes, S.W. et al. (2020) Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. Neuropsychopharmacology, 45(12), 2003-2011. Available from: https://doi.org/10.1038/s41386-020-0718-8
McCluskey, A. & de Vries, J. (2021) Help, I can't help: a qualitative study of psychiatric nurse's perspectives on their care for people who hear voices. Journal of Psychiatric and Mental Health Nursing, 28(2), 138-148. Available from: https://doi.org/10.1111/jpm.12642
McIntyre, R.S., Filteau, M.J., Martin, L., Patry, S., Carvalho, A., Cha, D.S. et al. (2014) Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. Journal of Affective Disorders, 156, 1-7. Available from: https://doi.org/10.1016/j.jad.2013.10.043
McMillan, R. & Fernandez, A. (2022) Understanding subjective experience in psychedelic-assisted psychotherapy: the need for phenomenology. Australian and New Zealand Journal of Psychiatry, 57, 783-788. Available from: https://doi.org/10.1177/00048674221139962
Nakagawa, A., Mitsuda, D., Sado, M., Abe, T., Fujisawa, D., Kikuchi, T. et al. (2017) Effectiveness of supplementary cognitive-behavioral therapy for pharmacotherapy-resistant depression: a randomized controlled trial. The Journal of Clinical Psychiatry, 78(8), 1126-1135. Available from: https://doi.org/10.4088/JCP.15m10511
Nutt, D., Spriggs, M. & Erritzoe, D. (2023) Psychedelics therapeutics: what we know, what we think, and what we need to research. Neuropharmacology, 223, 109257. Available from: https://doi.org/10.1016/j.neuropharm.2022.109257
Pedersen, W., Copes, H. & Gashi, L. (2021) Narratives of the mystical among users of psychedelics. Acta Sociologica, 64, 230-246.
Penn, A., Dorsen, C.G., Hope, S. & Rosa, W.E. (2021) Psychedelic-assisted therapy: emerging treatments in mental health disorders. The American Journal of Nursing, 121(6), 34-40. Available from: https://doi.org/10.1097/01.NAJ.0000753464.35523.29
Romeo, B., Karila, L., Martelli, C. & Benyamina, A. (2020) Efficacy of psychedelic treatments on depressive symptoms: a meta-analysis. Journal of Psychopharmacology, 34(10), 1079-1085. Available from: https://doi.org/10.1177/0269881120919957
Souza, L.H., Salum, G.A., Mosqueiro, B.P., Caldieraro, M.A., Guerra, T.A. & Fleck, M.P. (2016) Interpersonal psychotherapy as add-on for treatment-resistant depression: a pragmatic randomized controlled trial. Journal of Affective Disorders, 193, 373-380. Available from: https://doi.org/10.1016/j.jad.2016.01.004
Stauffer, C.S., Anderson, B.T., Ortigo, K.M. & Woolley, J. (2021) Psilocybin-assisted group therapy and attachment: observed reduction in attachment anxiety and influences of attachment insecurity on the psilocybin experience. ACS Pharmacology & Translational Science, 4(2), 526-532. Available from: https://doi.org/10.1021/acsptsci.0c00169
Sullivan, H.S. (1947) Conceptions of modern psychiatry. New York: William Alanson White Psychiatric Foundation.
Town, J.M., Abbass, A., Stride, C. & Bernier, D. (2017) A randomised controlled trial of intensive short-term dynamic psychotherapy for treatment resistant depression: the Halifax depression study. Journal of Affective Disorders, 214, 15-25. Available from: https://doi.org/10.1016/j.jad.2017.02.035
Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L. et al. (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. The American Journal of Psychiatry, 163(1), 28-40. Available from: https://doi.org/10.1176/appi.ajp.163.1.28
Watts, D., Day, C., Krzanowski, J., Nutt, D. & Carhart-Harris, R. (2017) Patients' accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology, 57, 520-564.
Watts, R. & Luoma, J. (2020) The use of the psychological flexibility model to support psychedelic assisted therapy. Journal of Contextual Behavioural Science, 15, 92-102.
White, M.R., Stein-Parbury, J., Orr, F. & Dawson, A. (2019) Working with consumers who hear voices: the experience of early career nurses in mental health services in Australia. International Journal of Mental Health Nursing, 28(2), 605-615. Available from: https://doi.org/10.1111/inm.12566
Wiles, N., Hollinghurst, S., Mason, V., Musa, M., Burt, V., Hyde, J. et al. (2008) A randomized controlled trial of cognitive behavioural therapy as an adjunct to pharmacotherapy in primary care based patients with treatment resistant depression: a pilot study. Behavioural and Cognitive Psychotherapy, 36, 21-33.
Wiles, N., Thomas, L., Turner, N., Garfield, D., Kounali, J., Campbell, D. et al. (2016) Ong-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial. Lancet Psychiatry, 3, 137-144.
Wolff, M., Evens, R., Mertens, L.J., Koslowski, M., Betzler, F., Grunder, G. et al. (2020) Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance. Frontiers in Psychiatry, 11, 5. Available from: https://doi.org/10.3389/fpsyt.2020.00005
Yaden, D.B., Earp, D., Graziosi, M., Friedman-Wheeler, D., Luoma, J.B. & Johnson, M.W. (2022) Psychedelics and psychotherapy: cognitive-behavioral approaches as default. Frontiers in Psychology, 13, 873279. Available from: https://doi.org/10.3389/fpsyg.2022.873279
Zeifman, R.J., Wagner, A.C., Monson, C.M. & Carhart-Harris, R.L. (2023) How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change. Journal of Affective Disorders, 334, 100-112. Available from: https://doi.org/10.1016/j.jad.2023.04.105